CAPITOL H FPO [CAJ] (CAJ.AX) Financials
CAJ.AX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2023 | 318.2 million | 180.1 million |
| March 31, 2023 | 318.2 million | 180.1 million |
| Dec. 31, 2022 | 312.9 million | 173.5 million |
| Sept. 30, 2022 | 312.9 million | 173.5 million |
CAJ.AX Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2023 | 4.9 million | 1.2 million |
| March 31, 2023 | 4.9 million | 1.2 million |
| Dec. 31, 2022 | 5.5 million | ? |
| Sept. 30, 2022 | 5.5 million | ? |
CAJ.AX Net Income
| Date | Net Income |
|---|---|
| June 30, 2023 | 1.9 million |
| March 31, 2023 | 1.9 million |
| Dec. 31, 2022 | -7.6 million |
| Sept. 30, 2022 | -7.6 million |
CAJ.AX Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2023 | 19.2 million | 123.4 million | 62.2 million |
| March 31, 2023 | 19.2 million | - | - |
| Dec. 31, 2022 | 14.8 million | 123.8 million | - |
| Sept. 30, 2022 | 15.0 million | - | - |
CAJ.AX Shares Outstanding
CAJ.AX Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2023 | 6.0 million | - | 83.5 million | - |
| March 31, 2023 | 6.0 million | - | - | - |
| Dec. 31, 2022 | 2.4 million | - | 70.6 million | - |
| Sept. 30, 2022 | 2.4 million | - | - | - |
CAJ.AX Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2023 | 111.5 million | 93.1 million |
| March 31, 2023 | 55.8 million | 43.8 million |
| Dec. 31, 2022 | 98.1 million | 79.3 million |
| Sept. 30, 2022 | 49.0 million | 37.7 million |
CAJ.AX
Price: A$0.38
Dividend Yield: 2.34%
Forward Dividend Yield: 2.08%
Payout Ratio: -80.00%
Dividend Per Share: 0.01 AUD
Earnings Per Share: -0.01 AUD
P/E Ratio: 30
Exchange: ASX
Sector: Healthcare
Industry: Diagnostics & Research
Country: Australia
Market Capitalization: 413.1 million
Average Dividend Frequency: 2
Years Paying Dividends: 7
DGR3: 13.33%
DGR5: 8.00%